Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osalidine for postoperative patient-controlled analgesia after thoracoscopic lung segmentectomy
ChiCTR2500099889Phase 4Recruiting
- Sponsor
- Shenzhen Nanshan People's Hospital
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oliceridine and sufentanil in postoperative pain (3 arms), sponsored by Shenzhen Nanshan People's Hospital. Primary endpoint: Visual Analogue Scale. Started Mar 2025; status: recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500099889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099889.